This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Non-Hodgkin lymphoma
  • /
  • Bendamustine in patients with rituximab-refractory...
Journal

Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.

Read time: 1 mins
Published:10th Jan 2008
Author: Friedberg JW, Cohen P, Chen L, Robinson KS, Forero-Torres A, La Casce AS, et al.
Availability: Free full text
Ref.:J Clin Oncol. 2008;26:204-10.
DOI:10.1200/JCO.2007.12.5070
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest